Research Impact

h-index

N/A

Research impact score

Publications

0

Total publications

Trial Results

0

Published trial results

Citations

0

Total citations

Drug Portfolio

Analytics

Trial Phases

Phase 21

Trial Status

Completed1

Role Distribution

Principal Investigator1
PI Rate100%

Activity Timeline

Research Network

Collaboration Network

45 collaborators·81 connections
Network Legend
KOL
Current Investigator
CO
High-influence Collaborator
CO
Collaborator
Click: view details
Double-click: go to profile
Drag: move node

Research Areas & Affiliations

Affiliations

Centre Francois Baclesse-CAEN

Similar Key Opinion Leaders

Discover other key opinion leaders with similar research profiles, therapeutic areas, and collaboration networks.

10 similar investigators found

Yves BECOUARN, Dr

Institut Bergonié Bordeaux

Related
2 trials

Shared therapeutic areas:

Malignant Neoplasm of EsophagusMalignant Neoplasm of Stomach

Worked with same sponsors:

UNICANCER
Collaborated on 1 trial
Similarity Score24%

You Heng LAM, Dr

Centre Paul Papin-ANGERS

Related
1 trials

Shared therapeutic areas:

Malignant Neoplasm of EsophagusMalignant Neoplasm of Stomach

Worked with same sponsors:

UNICANCER
Collaborated on 1 trial
Similarity Score24%

Leila BENGRINE LEFEVRE, Dr

Hôpital Saint Antoine

Related
1 trials

Shared therapeutic areas:

Malignant Neoplasm of EsophagusMalignant Neoplasm of Stomach

Worked with same sponsors:

UNICANCER
Collaborated on 1 trial
Similarity Score24%

Eric FRANCOIS, Dr

Centre Antoine Lacassagne, Nice

Related
4 trials

Shared therapeutic areas:

Malignant Neoplasm of EsophagusMalignant Neoplasm of Stomach

Worked with same sponsors:

UNICANCER
Collaborated on 1 trial
Similarity Score24%

Hervé PERRIER, Dr

Hôpital Saint Joseph

Related
1 trials

Shared therapeutic areas:

Malignant Neoplasm of EsophagusMalignant Neoplasm of Stomach

Worked with same sponsors:

UNICANCER
Collaborated on 1 trial
Similarity Score24%

Emmanuel MAILLARD, Dr

CHR Annecy

Related
1 trials

Shared therapeutic areas:

Malignant Neoplasm of EsophagusMalignant Neoplasm of Stomach

Worked with same sponsors:

UNICANCER
Collaborated on 1 trial
Similarity Score24%

Eric TERREBONNE, Dr

Hôpîtal haut Lévèque

Related
1 trials

Shared therapeutic areas:

Malignant Neoplasm of EsophagusMalignant Neoplasm of Stomach

Worked with same sponsors:

UNICANCER
Collaborated on 1 trial
Similarity Score24%

Christophe BORG, Pr

Hôpital Andre Boulloche-MONTBELIARD

Related
1 trials

Shared therapeutic areas:

Malignant Neoplasm of EsophagusMalignant Neoplasm of Stomach

Worked with same sponsors:

UNICANCER
Collaborated on 1 trial
Similarity Score24%

Marie-Claire KAMINSKY, Dr

Centre Alexis Vautrin-VANDOEUVRE LES NANCY

Related
1 trials

Shared therapeutic areas:

Malignant Neoplasm of EsophagusMalignant Neoplasm of Stomach

Worked with same sponsors:

UNICANCER
Collaborated on 1 trial
Similarity Score24%

Bruno BUECHER, Dr

Institut Curie Paris

Related
1 trials

Shared therapeutic areas:

Malignant Neoplasm of EsophagusMalignant Neoplasm of Stomach

Worked with same sponsors:

UNICANCER
Collaborated on 1 trial
Similarity Score24%

Publications (0)

No publications found for this investigator.

Clinical Trials (1)

Showing 1 of 1 trials

NCT01443065Phase 2PrincipalInvestigator

MEGA (Met or EGFR Inhibition in Gastroesophageal Adenocarcinoma): FOLFOX Alone or in Combination With AMG 102 or Panitumumab as First-line Treatment in Patients With Advanced Gastroesophageal Adenocarcinoma

Malignant Neoplasm of EsophagusMalignant Neoplasm of Stomach
Completed

All 1 trials loaded